SPC Logo

Oilatum Junior Cream

Last Updated on eMC 08-Apr-2016 View changes  | GlaxoSmithKline Consumer Healthcare Contact details

1. Name of the medicinal product

Oilatum Cream

Oilatum Junior Cream

2. Qualitative and quantitative composition

Contains Light Liquid Paraffin 6.0% w/w and White Soft Paraffin 15.0% w/w in a cream base.

Also contains cetostearyl alcohol and potassium sorbate.

For a full list of excipients, see Section 6.1.

3. Pharmaceutical form

Cream

A white to off-white cream

4. Clinical particulars
4.1 Therapeutic indications

Oilatum Cream is indicated in the treatment of contact dermatitis, atopic eczema, senile pruritus, ichthyosis and related dry skin conditions.

4.2 Posology and method of administration

Oilatum Cream may be used as often as required. Apply to the affected area and rub in well. It is especially effective after washing when the sebum content of the stratum corneum may be depleted resulting in excessive moisture loss.

Oilatum Cream is suitable for adults, children and the elderly.

4.3 Contraindications

PL 00079/0705

None.

PL 00079/0706

Should not be used in patients with known hypersensitivity to any of the ingredients.

4.4 Special warnings and precautions for use

Oilatum Cream should be used with caution in patients with a known sensitivity or allergy to white soft paraffin or light liquid paraffin (WSP-LLP) or to any of the excipients in the preparation.

Cetostearyl alcohol and potassium sorbate may cause local skin reactions (e.g. contact dermatitis).

PL 0079/0705

Hospital users should follow local procedures and policies for using topical products on in-patients.

4.5 Interaction with other medicinal products and other forms of interaction

None

4.6 Pregnancy and lactation

Fertility

There are no data on the use of topical Oilatum Cream on human fertility

Pregnancy

There are no data on the use of topical Oilatum Cream in pregnant women. No effects during pregnancy are anticipated, since systemic exposure to WSP-LLP is low.

Lactation

It is not known if Oilatum Cream is excreted in human milk. Risk to the infant is likely to be low since systemic exposure is low. Patients should be advised to ensure that any residual product is fully washed off the breast prior to breast-feeding.

4.7 Effects on ability to drive and use machines

None

4.8 Undesirable effects

May cause irritation in patients hypersensitive to any of the ingredients.

Adverse drug reactions (ADRs) are listed below by MedDRA system organ class and by frequency. Frequencies are defined as: very common (≥1/10), common (≥1/100 and <1/10), uncommon (≥1/1,000 and < 1/100), rare (≥1/10,000 and <1/1,000); very rare (<1/10,000) and not known (cannot be estimated from the available data).

Post-marketing data

Skin and Subcutaneous Tissue Disorders

Rare: Application site reactions including application site erythema, rash, pain, pruritus, skin burning sensation.

Immune System Disorders

Rare: Application site hypersensitivity reactions including application site dermatitis.

4.9 Overdose

Symptoms and signs

The product is intended for topical use only. Ingestion may cause gastrointestinal irritation with nausea, vomiting and diarrhoea. Excessive topical application should cause no untoward effects other than greasy skin.

Treatment

In case of accidental ingestion, management should be as clinically indicated or as recommended by the national poisons centre, where available.

5. Pharmacological properties
5.1 Pharmacodynamic properties

Light Liquid Paraffin and White Soft Paraffin exert an emollient effect by forming an occlusive film which reduces trans-epidermal water loss, thus helping to maintain normal skin humidity levels. Polyvinyl pyrrolidone enhances the strength and longevity of the occlusive film formed by the oil on the skin.

5.2 Pharmacokinetic properties

Not applicable.

5.3 Preclinical safety data

White Soft Paraffin and Light Liquid Paraffin have been used in pharmaceutical and cosmetic preparations for many years. The formulation contains excipients that are commonly used in such preparations. The safety of these substances is well established by common use over long periods in man.

6. Pharmaceutical particulars
6.1 List of excipients

Macrogol 1000 Monostearate

Cetostearyl alcohol

Glycerol

Potassium sorbate

Benzyl alcohol

Citric acid monohydrate

Povidone

Purified water

6.2 Incompatibilities

None

6.3 Shelf life

PL 00079/0705

30 Months

PL 00079/0706

Three years

6.4 Special precautions for storage

PL 00079/0705

Do not store above 25°C

PL 00079/0706

Store below 25°C

6.5 Nature and contents of container

PL 00079/0705

350 ml and 500 ml pump pack: High density polyethylene bottle fitted with a mechanical pump dispenser (polyethylene/ polypropylene components).

1000 ml, 1050 ml, 1100 ml, 1150 ml pump pack: polypropylene container and lid, fitted with a mechanical pump dispenser (polypropylene components), utilising a follower plate (HDPE).

Not all pack sizes may be marketed.

PL 00079/0706

Internally lacquered, membrane sealed aluminium tube fitted with a polypropylene screw cap and packed into a carton. Pack size 40 g and 80 g.

Internally lacquered, membrane sealed aluminium tube fitted with a polyethylene screw cap and packed into a carton. Pack size 30 g and 50 g.

Laminate tubes with polypropylene caps packed into cartons. Pack sizes 100 g and 150 g

And 25 g, 50 g & 150 g in a high density polyethylene tube.

Not all pack sizes may be marketed.

6.6 Special precautions for disposal and other handling

None

7. Marketing authorisation holder

PL 00079/0705

Beecham Group plc,

trading as

Stiefel

980 Great West Road

Brentford, Middlesex

TW8 9GS

United Kingdom

PL 00079/0706

Beecham Group plc,

980 Great West Road

Brentford, Middlesex

TW8 9GS

United Kingdom

8. Marketing authorisation number(s)

PL 00079/0705

PL 00079/0706

9. Date of first authorisation/renewal of the authorisation

PL 00079/0705

28/10/2005

PL 00079/0706

07/12/2010

10. Date of revision of the text

PL 00079/0705

20/02/2014

PL 00079/0706

05/09/2013

Company contact details

GlaxoSmithKline Consumer Healthcare

Company image
Address

980 Great West Road, Brentford, Middlesex, TW8 9GS

Medical Information e-mail
Medical Information Direct Line

0800 783 8881

Customer Care direct line

0800 783 8881

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

light liquid paraffin, white soft paraffin

Legal categories

GSL - General Sales List

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue